BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25596057)

  • 1. [A case of thymic cancer effectively treated by weekly paclitaxel combined with carboplatin].
    Kondo R; Watanabe S; Ishikawa D; Tanaka T; Ohshima Y; Asakawa K; Sakagami T; Okajima M; Miura S; Hayashi Y; Tanaka J; Kagamu H; Yoshizawa H; Narita I
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2607-9. PubMed ID: 25596057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of recurrent invasive thymic cancer showing a stable disease to carboplatin plus paclitaxel].
    Igawa S; Yanagisawa N; Makita S; Iida Y; Maki S; Kimura Y; Otani S; Hayashi N; Takakura A; Katono K; Onoda S; Yamamoto M; Masuda N
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2161-3. PubMed ID: 21084818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thymic cancer effectively treated by combination chemotherapy of carboplatin and etoposide with concurrent radiotherapy].
    Kaira K; Watanabe R; Takise A; Endou K; Kamiyoshihara M; Mori M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1989-92. PubMed ID: 16282742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced thymic cancer treated with carboplatin and paclitaxel in a patient undergoing hemodialysis.
    Miura S; Kagamu H; Sakai T; Nozaki K; Asakawa K; Moro H; Okajima M; Watanabe S; Yamamoto S; Iino N; Goto S; Kazama JJ; Yoshizawa H; Narita I
    Intern Med; 2015; 54(1):55-8. PubMed ID: 25742894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma.
    Igawa S; Murakami H; Takahashi T; Nakamura Y; Tsuya A; Naito T; Kaira K; Ono A; Shukuya T; Tamiya A; Endo M; Yamamoto N
    Lung Cancer; 2010 Feb; 67(2):194-7. PubMed ID: 19409644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma--three cases.
    Komatsu Y; Koizumi T; Tanabe T; Hatayama O; Yasuo M; Okada M; Yamamoto H; Kubo K; Sasabayashi M; Tsunoda T
    Anticancer Res; 2006; 26(6C):4851-5. PubMed ID: 17214351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer.
    Ramalingam S; Perry MC; La Rocca RV; Rinaldi D; Gable PS; Tester WJ; Belani CP
    Cancer; 2008 Aug; 113(3):542-6. PubMed ID: 18512224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer.
    Furugen M; Sekine I; Tsuta K; Horinouchi H; Nokihara H; Yamamoto N; Kubota K; Tamura T
    Jpn J Clin Oncol; 2011 Aug; 41(8):1013-6. PubMed ID: 21742653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of intrapericardial administration of carboplatin following systemic chemotherapy in a case of advanced thymic cancer with cardiac tamponade].
    Okada M; Koizumi T; Yasuo M; Tsushima K; Urushihata K; Yamaguchi S; Hanaoka M; Fujimoto K; Kubo K
    Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):968-72. PubMed ID: 17233396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
    Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
    Langer CJ; Leighton J; McAleer C; Comis R; O'Dwyer P; Ozols R
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of lung cancer showing marked reduction of pleural effusion by bevacizumab in combination with carboplatin and paclitaxel].
    Hama M; Komatsu Y; Hachiya T
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1877-9. PubMed ID: 22083202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
    Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
    Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T
    Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
    Belani CP; Ramalingam S; Perry MC; LaRocca RV; Rinaldi D; Gable PS; Tester WJ
    J Clin Oncol; 2008 Jan; 26(3):468-73. PubMed ID: 18202422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: a phase I study.
    Sehouli J; Stengel D; Elling D; Ortmann O; Blohmer J; Riess H; Lichtenegger W;
    Gynecol Oncol; 2002 May; 85(2):321-6. PubMed ID: 11972395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of carboplatin and weekly paclitaxel combination chemotherapy in advanced non-small cell lung cancer: a Kansai Clinical Oncology Group study.
    Hirabayashi M; Endoh K; Teramachi M; Okuda M; Yamaguchi K; Fukuda K; Tokuhisa H; Kagioka H; Nakai N; Nakade M
    Lung Cancer; 2004 Jun; 44(3):355-62. PubMed ID: 15140549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
    Abaid LN; Micha JP; Rettenmaier MA; Brown JV; Mendivil AA; Lopez KL; Goldstein BH
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):101-7. PubMed ID: 23660691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
    Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.